Positron to host special ASNC 2010 symposium focusing on cardiac PET

Positron Corporation (OTCBB:POSC) is pleased to announce K. Lance Gould M.D. as the keynote speaker for their upcoming cardiac PET symposium, held at the American Society of Nuclear Cardiology (ASNC) annual meeting, September 23-26 in Philadelphia, PA.

Positron will be hosting a special ASNC 2010 symposium focused on cardiac PET, Saturday, September 25^th, in the downtown Marriott Independence Ballroom at 7:00pm.  Dr. Gould's lecture, "Quantitative myocardial perfusion imaging and absolute coronary flow reserve by PET, a current paradigm change in cardiovascular medicine," will be the highlight of the evening.

Dr. Gould is a renowned cardiac PET expert and a professor of cardiovascular medicine at the University of Texas Medical School in Houston. He holds the Martin Bucksbaum Distinguished University Chair (the only one in cardiology in the University of Texas system) and is executive director of the endowed Weatherhead P.E.T. Center for Preventing and Reversing Atherosclerosis.  His responsibilities include research, teaching, and daily hands-on performance of PET scans in his large clinical practice based on PET guided management of CAD. 

Joseph Oliverio, chief technical officer of Positron states, "We are honored to have the world's foremost expert on Cardiac PET and quantitative imaging with Rb-82 speak at our symposium.   Dr. Gould's talk will update the audience on the growing new paradigm for cardiac imaging as the guide to managing coronary artery disease, which is also the basis for the future release of our new comprehensive quantitative workstation."

"PET is a clear window into the heart - its past, present and future. It's a critical tool that provides the clarity and insight needed to treat and prevent coronary artery disease," stated Dr. Gould. 

Routine quantitative stress PET perfusion imaging for flow in cc/min/gm and absolute coronary flow reserve (CFR) are measured routinely in every patient as the guide for revascularization procedures, second opinions, and secondary as well as primary prevention by intense, comprehensive lifestyle and pharmacologic treatment integrated with PET results and follow-up. Quantitative PET defines the level of perfusion and CFR causing ischemia and therefore the thresholds for guiding revascularization procedures or medical treatment.